Update on treatment of polymyalgia rheumatica
Submitted: 17 August 2017
Accepted: 8 February 2018
Published: 27 March 2018
Accepted: 8 February 2018
Abstract Views: 5423
PDF: 3234
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- M. Cutolo, IL-1Ra: its role in rheumatoid arthritis , Reumatismo: Vol. 56 No. s1 (2004)
- E. Mainardi, A. Montanelli, Antibodies anti granulocytic antigens in IBD: from microscopic morphology to antigenic specificity , Reumatismo: Vol. 58 No. 2 (2006)
- G. Brambilla, A. Brucato, Y. Adler, M. Bosetti, P. Coppini, A. Caforio, D. Spodick, B. Canesi, Recurrent acute idiopathic pericarditis: rheumatologic therapy, autoantibodies and long term outcome , Reumatismo: Vol. 59 No. 1 (2007)
- V. Bruzzese, P. Scolieri, J. Pepe, Biclonal gammopathy of undetermined significance in a patient with systemic lupus erythematosus and antiphospholipid syndrome , Reumatismo: Vol. 73 No. 4 (2021)
- P. Versura, M. Frigato, B. Bernabini, R. Mulè, N. Malavolta, E.C. Campos, Ocular surface analysis in patients affected with rheumatic diseases , Reumatismo: Vol. 56 No. 4 (2004)
- F. De Leonardis, S. Aliverini, E. Bonacci, A.M. Buono, S. Bombardieri, G.F. Ferraccioli, C. Montecucco, L. Sinigaglia, F. Trotta, G. Valentini, Italian consensus on the recommendations about the use of methotrexate for the treatment of rheumatic diseases with a focus on rheumatoid arthritis: results from the “3E initiative” , Reumatismo: Vol. 62 No. 1 (2010)
- N.A.G. Gaafar, M. Aslani, Z. Aghazadeh, S.S. Mortazavi-Jahromi, A. Razavi, A. Mirshafiey, Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients , Reumatismo: Vol. 72 No. 2 (2020)
- F.M. Perrotta, S. Scriffignano, M. Fatica, M. Specchia, E. Lubrano, Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab , Reumatismo: Vol. 72 No. 3 (2020)
- U. Fiocco, M. Vezzù, L. Cozzi, S. Todesco, IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy , Reumatismo: Vol. 56 No. s1 (2004)
- F. Bagcier, O.V. Yurdakul, E. Ozduran, Top 100 cited articles on ankylosing spondylitis , Reumatismo: Vol. 72 No. 4 (2020)
<< < 35 36 37 38 39 40 41 42 43 44 > >>
You may also start an advanced similarity search for this article.